lactic acid and rifapentine

lactic acid has been researched along with rifapentine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, Y; Jiang, D; Li, J; Qiao, B; Wang, J; Wu, J; Zuo, Y1
Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF1
Britton, WJ; Chan, HK; Leung, SS; Parumasivam, T; Quan, DH; Triccas, JA1
Jiang, D; Liu, Y1
Chen, Z; Huang, J; Li, L; Li, Y; Zhang, G1

Other Studies

5 other study(ies) available for lactic acid and rifapentine

ArticleYear
Development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Drug Delivery Systems; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Staphylococcus aureus; Surface Properties; Tuberculosis, Osteoarticular

2015
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus

2015
Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: Preparation and in vitro aerosol characterization.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016, Jun-10, Volume: 88

    Topics: Administration, Inhalation; Aerosols; Antitubercular Agents; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Lactic Acid; Lung; Microscopy, Electron, Scanning; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin

2016
Effect of bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres on bone and joint tuberculosis in vitro.
    Cell biology international, 2017, Volume: 41, Issue:4

    Topics: Cell Differentiation; Cell Line, Tumor; Drug Carriers; Durapatite; Humans; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis, Osteoarticular; Wnt Signaling Pathway

2017
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization.
    Drug design, development and therapy, 2017, Volume: 11

    Topics: Animals; Bronchoscopy; Dogs; Female; Lactic Acid; Linezolid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Surface Properties; Tuberculosis, Pulmonary

2017